Stockscreener 앱 받기
11.22
0.44%
-0.045
전일 마감가:
$11.27
열려 있는:
$11.3
하루 거래량:
148.98K
Relative Volume:
0.08
시가총액:
$1.48B
수익:
$260.11M
순이익/손실:
$60.64M
주가수익비율:
26.10
EPS:
0.43
순현금흐름:
$92.29M
1주 성능:
-0.88%
1개월 성능:
-11.93%
6개월 성능:
+51.42%
1년 성능:
+58.47%
1일 변동 폭
$11.13
$11.33
1주일 범위
$11.07
$11.87
52주 변동 폭
$6.55
$13.54
Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile
명칭
Aurinia Pharmaceuticals Inc
전화
250-744-2487
주소
#140, 14315 - 118 AVENUE, EDMONTON, BC
AUPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AUPH
Aurinia Pharmaceuticals Inc
|
11.22 | 1.48B | 260.11M | 60.64M | 92.29M | 0.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
406.28 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.63 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.19 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
800.57 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
328.93 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-30 | 재개 | H.C. Wainwright | Buy |
| 2022-11-04 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-05-05 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-12-10 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-10-28 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-01-25 | 재확인 | H.C. Wainwright | Buy |
| 2020-11-03 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-17 | 개시 | BTIG Research | Buy |
| 2020-05-05 | 개시 | Cowen | Outperform |
| 2020-01-10 | 개시 | Jefferies | Buy |
| 2019-12-16 | 재확인 | H.C. Wainwright | Buy |
| 2018-03-16 | 재확인 | Cantor Fitzgerald | Overweight |
| 2018-02-08 | 개시 | RBC Capital Mkts | Outperform |
| 2017-10-30 | 재확인 | H.C. Wainwright | Buy |
| 2017-05-18 | 재확인 | H.C. Wainwright | Buy |
| 2017-04-11 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-03-22 | 재확인 | FBR & Co. | Outperform |
| 2016-12-30 | 재확인 | H.C. Wainwright | Buy |
| 2016-08-17 | 재확인 | H.C. Wainwright | Buy |
| 2016-06-30 | 개시 | H.C. Wainwright | Buy |
| 2015-05-08 | 개시 | MLV & Co | Buy |
모두보기
Aurinia Pharmaceuticals Inc 주식(AUPH)의 최신 뉴스
Can Aurinia Pharmaceuticals Inc. stock reach $100 price target2025 Trade Ideas & Weekly Top Performers Watchlists - newser.com
Can Aurinia Pharmaceuticals Inc. (IKAP) stock reach $200 price targetTrade Risk Report & Risk Adjusted Buy and Sell Alerts - newser.com
Statistical indicators supporting Aurinia Pharmaceuticals Inc.’s strengthTrade Volume Summary & Daily Chart Pattern Signals - newser.com
Technical analysis overview for Aurinia Pharmaceuticals Inc. stockTrade Ideas & Real-Time Chart Breakout Alerts - newser.com
Real time breakdown of Aurinia Pharmaceuticals Inc. stock performance2025 Top Decliners & AI Based Buy and Sell Signals - newser.com
What the charts say about Aurinia Pharmaceuticals Inc. todayRate Hike & Daily Stock Trend Reports - newser.com
Market reaction to Aurinia Pharmaceuticals Inc.’s recent newsWeekly Market Report & Risk Controlled Swing Alerts - newser.com
Predicting Aurinia Pharmaceuticals Inc. trend using moving averages2025 Geopolitical Influence & Weekly High Momentum Picks - newser.com
Aurinia Pharmaceuticals' (AUPH) "Hold (C)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Analyzing net buyer seller activity in Aurinia Pharmaceuticals Inc.2025 Fundamental Recap & Free Community Consensus Stock Picks - newser.com
Can trapped investors hope for a rebound in Aurinia Pharmaceuticals Inc.Weekly Profit Recap & Fast Moving Stock Trade Plans - newser.com
Combining machine learning predictions for Aurinia Pharmaceuticals Inc.Portfolio Return Report & Stock Portfolio Risk Management - newser.com
Will Aurinia Pharmaceuticals Inc. price bounce be sustainableMarket Risk Summary & Proven Capital Preservation Methods - newser.com
Is Shriram Asset Management Company Limited a Hybrid Growth Value Stock Worth HoldingPrice Gap Trading Strategies & Achieve Triple Digit Returns - earlytimes.in
Aurinia Pharmaceuticals Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
How Aurinia Pharmaceuticals Inc. (IKAP) stock compares with top peers2025 Short Interest & Community Consensus Picks - newser.com
Pattern recognition hints at Aurinia Pharmaceuticals Inc. upsidePortfolio Update Report & Proven Capital Preservation Methods - newser.com
Using AI based signals to follow Aurinia Pharmaceuticals Inc.July 2025 EndofMonth & Weekly Momentum Stock Picks - newser.com
Forecasting Aurinia Pharmaceuticals Inc. price range with options dataQuarterly Market Review & High Return Trade Opportunity Guides - newser.com
Could Regulatory Scrutiny Shift the Risk Profile for Aurinia Pharmaceuticals (AUPH)? - Sahm
How high can Aurinia Pharmaceuticals Inc. stock go2025 Momentum Check & High Accuracy Investment Signals - newser.com
Smart tools for monitoring Aurinia Pharmaceuticals Inc.’s price actionGap Up & Verified Stock Trade Ideas - newser.com
TD Cowen Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating, Maintains Target Price $11 - 富途牛牛
Aurinia Pharmaceuticals Hits Day Low of $11.04 Amid Price Pressure - Markets Mojo
Aurinia responds after top FDA official’s comment on lead drug - MSN
Aurinia Sinks After FDA Official Questions Its Drug in Post - MSN
FDA official’s comments spark Aurinia sell-off; Halozyme buys a biotech - BioPharma Dive
Why retail investors pile into Aurinia Pharmaceuticals Inc. stock2025 Key Lessons & Technical Pattern Based Signals - newser.com
Can swing trading help recover from Aurinia Pharmaceuticals Inc. lossesJuly 2025 Patterns & Free Fast Entry Momentum Trade Alerts - newser.com
Will earnings trigger a reversal in Aurinia Pharmaceuticals Inc.Market Trend Review & Smart Investment Allocation Insights - newser.com
What analysts say about Aurinia Pharmaceuticals Inc stockEconomic Impact on Stocks & Double Digit Profit Strategies - earlytimes.in
Aurinia Defends Benefit/Risk Profile of Lupus Nephritis Treatment After FDA Official's Retracted LinkedIn Post - MarketScreener
Aurinia Pharma rises after defending lupus drug - TradingView
Aurinia Sinks After FDA Official Questions Its Drug on LinkedIn - Bloomberg.com
Aurinia Pharma Stands By Lupus Drug After FDA Official’s Retracted Post Sparks 16% Selloff — Retail Stays Bullish On Recovery - MSN
Jefferies reiterates Hold rating on Aurinia Pharmaceuticals stock at $10 price target - Investing.com Canada
Aurinia Pharmaceuticals stock hits 52-week high at 13.45 USD By Investing.com - Investing.com Nigeria
Aurinia Pharmaceuticals Inc (AUPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Aurinia Pharmaceuticals Inc 주식 (AUPH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| TANG KEVIN | Director |
Aug 05 '25 |
Buy |
11.68 |
200,000 |
2,336,000 |
11,329,500 |
| TANG KEVIN | Director |
Aug 04 '25 |
Buy |
11.34 |
100,000 |
1,134,000 |
11,129,500 |
| Keenan Greg | Chief Medical Officer |
Aug 01 '25 |
Sale |
10.50 |
20,000 |
210,000 |
133,484 |
| Keenan Greg | Chief Medical Officer |
Mar 07 '25 |
Sale |
8.23 |
8,305 |
68,350 |
153,484 |
| Greenleaf Peter | Chief Executive Officer |
Mar 03 '25 |
Sale |
8.00 |
195,593 |
1,564,744 |
1,953,892 |
| Greenleaf Peter | Chief Executive Officer |
Mar 04 '25 |
Sale |
7.92 |
164,947 |
1,306,380 |
1,788,945 |
| Keenan Greg | Chief Medical Officer |
Mar 03 '25 |
Sale |
8.00 |
12,239 |
97,912 |
161,789 |
| Miller Joseph M | Chief Financial Officer |
Mar 03 '25 |
Sale |
8.00 |
61,859 |
494,872 |
633,515 |
| Miller Joseph M | Chief Financial Officer |
Mar 04 '25 |
Sale |
7.92 |
56,154 |
444,740 |
577,361 |
| Robertson Stephen P. | EVP, General Counsel |
Mar 03 '25 |
Sale |
8.00 |
64,872 |
518,976 |
566,883 |
0.11%
2.69%
자본화:
|
볼륨(24시간):